Cleared Traditional

K243841 - Sparta Infusion Set for Insulin

K243841 is an FDA 510(k) clearance for Sparta Infusion Set for Insulin, manufactured by Deka Research and Development. The device is a Class 2 Chemistry device with product code FPA cleared through the Traditional 510(k) pathway after a 231-day FDA review.

K243841 · Deka Research and Development · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2025
Decision
231d
Days
Class 2
Risk

K243841 is an FDA 510(k) clearance for the Sparta Infusion Set for Insulin. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Deka Research and Development (Manchester, US). The FDA issued a Cleared decision on August 1, 2025 after a review of 231 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 880.5440 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Deka Research and Development devices

FDA 510(k) Submission Details - K243841

510(k) Number K243841 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 13, 2024
Decision Date August 01, 2025
Days to Decision 231 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
143d slower than avg
Panel avg: 88d · This submission: 231d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 532
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K243841.
BD Alaris Pump Infusion Set
K250325 · Carefusion (Bd) · Oct 2025
EZ™ IV Administration Set
K251814 · Epic Medical Pte. , Ltd. · Aug 2025
SteadiSet infusion set
K251854 · Tandem Diabetes Care · Aug 2025
Infusomat® Space Volumetric Infusion Pump Administration Sets
K243392 · B.Braun Medical, Inc. · Jul 2025
Clave™ Neutral-Displacement Needlefree Connectors
K250616 · Icu Medical, Inc. · Jun 2025
SteadiSet Infusion Set
K242692 · Capillary Biomedical, LLC · May 2025